Citations

Showing 10 of 107852 citations.

Single-position robot-assisted lateral lumbar corpectomy with minimally invasive posterior spinal fusion for traumatic burst fracture showing MRI-demonstrated indirect decompression: illustrative case
Fraipont, Genevieve , Pennington, Zach , Diaz-Aguilar, Luis Daniel , Pham, Martin H. , Fraipont, Genevieve M , Pennington, Zach , Pham, Martin H , Beyer, Ryan S.

Mayo Clinic

Journal of Neurosurgery: Case Lessons | July 22, 2026 | Volume: 12 | Issue: 3 | Pages: No page available

10.3171/case26118 | PMID 42475751 Get It

BACKGROUND Ligamentotaxis-based indirect decompression using lateral approaches is well described for degenerative lumbar disease, yet its application in managing burst fractures remains underexplored. OBSERVATIONS A 72-year-old osteopenic male with an L4 burst fracture underwent a single-position robot-assisted lateral L4 corpectomy, L2–3 oblique lumbar interbody fusion, L5–S1 lateral anterior lumbar interbody fusion, and robot-assisted percutaneous segmental fixation from L2 to the ilium. Postoperative MRI demonstrated significant indirect decompression with a decrease in ligamentous buckling and restoration of the spinal canal cross-sectional area. The ligamentotaxis created by the height and lordosis restoration produced adequate decompression without resection of the ventral retropulsed fragments or posterior direct decompression. LESSONS This case illustrates that single-position lateral lumbar corpectomy can achieve indirect decompression while sparing the morbidity of an open posterior approach. To the authors’ knowledge, this is the first report with MRI evidence of indirect decompression following single-position lateral lumbar corpectomy. https://thejns.org/doi/10.3171/CASE26118
A novel microvascular arterio-neural pathway for intraneural ganglion cyst formation secondary to cystic adventitial disease: illustrative case
Piyawattanametha, Nontaphon , Ruiter, Godard C. W. de , Reina, Miguel Ángel , Amrami, Kimberly K. , Kalra, Manju, Spinner, Robert J. , Reina, Miguel Angel , Spinner, Robert J , Marek, Tomáš , Kalra, Manju

Mayo Clinic

Journal of Neurosurgery: Case Lessons | July 22, 2026 | Volume: 12 | Issue: 3 | Pages: No page available

10.3171/case26411 | PMID 42475738 Get It

BACKGROUND Cystic adventitial disease (CAD) and intraneural ganglion cysts (IGCs) are rare mucinous lesions typically linked to an articular origin via macroscopic conduits. While secondary propagation between vascular and neural systems may occur through shared fascial sheaths, a direct microvascular route has not been previously described. OBSERVATIONS A 60-year-old man presented with progressive left tibial neuropathy. High-resolution 7T MRI and surgery revealed a large popliteal CAD lesion connecting to the knee joint via the middle genicular artery, alongside a secondary tibial IGC lacking an independent articular nerve connection. Findings demonstrated that high-pressure CAD mucin tracked along a small connecting vascular branch, creating a novel microvascular arterio-neural pathway to infiltrate the tibial nerve. Targeted articular branch disconnection and cyst decompression yielded significant clinical improvement, with no recurrence on 7-month follow-up 7T MRI. LESSONS This case expands the unifying articular theory, demonstrating that synovial fluid propagation can exploit a microvascular arterio-neural pathway rather than strictly macroscopic fascial planes. High-resolution 7T MRI is essential for visualizing these subtle connections. Successful management requires meticulous identification and disconnection of the primary joint connection to prevent recurrence. https://thejns.org/doi/10.3171/CASE26411
“ICH-CARE”: ICH -integrated C are for A ccelerated R esponse to
Salman, Saif, English, Stephen, Mooney, Lesia, Miller, David, Ng, Lauren, Kramer, Christopher, Ombada, Mutaz , Tawk, Rabih, Salman, Saif , Kramer, Christopher, Tawk, Rabih G. , Freeman, William D.

Mayo Clinic

No container title available | July 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.07.18.26358392 Get It

Abstract Introduction Intracerebral hemorrhage (ICH) carries higher morbidity and mortality than ischemic stroke. Recent studies have demonstrated improved patient outcomes by applying ultra-early bundled interventions including blood pressure management, coagulopathy reversal, and osmotic therapy. Effective strategies to deliver these ultra-early treatment options are currently being explored. On December 19th, 2022, the Mayo Clinic Comprehensive Stroke Center (CSC) launched the “ICH Phases” communication system to accelerate ICH patient care. Objective To evaluate adherence to the AHA/ASA guidelines in acute ICH care following the implementation of our novel-tiered paging system. Methods We retrospectively reviewed patients admitted with spontaneous ICH during 2024 and 2025. We excluded traumatic cases. We extracted clinical data such as time to imaging, documentation of ICH score, blood pressure control, reversal of anticoagulation, venous thrombo-embolism (VTE) prophylaxis and discharge disposition. Results Among 67 patients, 68.7% underwent CT imaging within 25 minutes. We documented the ICH score within 6 hours in 82.9% of patients. Nearly 94.7% of patients with SBP>140 mm Hg received antihypertensive therapy, yet only 18% reached target BP within 60 minutes. We completed the reversal of anticoagulation within 120 minutes in 75% of patients. VTE prophylaxis was initiated within 24 hours in 91% of patients. Discussion Our novel system demonstrated adherence to the AHA/ASA guidelines, and time sensitive benchmarks in neuroimaging, reversal of anticoagulation, and VTE prophylaxis. Early BP control remains a challenge, that highlights the discrepancy between guidelines and real-ground implementation. Conclusion A novel tiered paging system is effective for enhancing early ICH care. Such a holistic system remains critical for sustained improvement in quality of care.
Quantitative Prognostic Modeling in Aneurysmal Subarachnoid Hemorrhage: Multicenter Validation of the eSAH Score
Salman, Saif, Moy, Constantin Graf von , Haidenberger, Flora, Ahmed, Mahlika, Foettinger, Fabian, Sharma, Rohan, Gutierrez-Aguirre, Salvador, Toledo, Otávio de, Patel, Vishal , Yujia-Wei, David, Brandmeir, Nicholas, Lakkaraju, Kausik , Ombada, Mutaz , Aguilar-Salinas, Pedro, Miller, David, Erickson, B E, Hanel, Ricardo, Tawk, Rabih, Byrne, Richard, Salman, Saif , Haidenberger, Flora, Gutierrez‐Aguirre, Salvador F. , Toledo, Otavio F. De , Patel, Vishal, Jahromi, Behnam Rezai , Brandmeir, Nicholas J. , Erickson, B E, Tawk, Rabih G. , Freeman, William D.

Mayo Clinic

No container title available | July 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.07.18.26358390 Get It

Abstract Background aneurysmal subarachnoid hemorrhage (aSAH) is neurological emergency associated with substantial mortality and disability. Current grading systems such as the modified Fisher Scale (mFS) and World Federation of Neurological Societies (WFNS) score, rely on semiquantitative and examination based assessments. Hence, they demonstrate limited predictive precision. The enhanced subarachnoid hemorrhage (eSAH) score is a simplified quantitative model integrating age, Glasgow Coma Scale (GCS), and cisternal subarachnoid hemorrhage volume (SAHV) to predict clinical outcomes after aSAH. Methods We performed a retrospective multicenter cohort study that included 1088 patients across three tertiary-care centers the United States. Predictive performance for unfavorable functional outcome, in-hospital mortality and delayed cerebral ischemia (DCI) was evaluated using receiver operating characteristic (ROC) analysis and area under the curve (AUC). Comparative analyses were performed and compared to the WFNS and mFS grading systems. Results the eSAH score demonstrated excellent discrimination for unfavorable functional outcome at discharge ( AUC 0.89 ) and in-hospital mortality (AUC 0.87). The DCI subscore demonstrated good discriminatory performance for predicting DCI (AUC 0.77). Compared with conventional grading systems, this was superior to both the WFNS (AUC 0.75) and the mFS ( AUC 0.70). increasing eSAH scores were additionally associated with progressively higher rates of mortality and unfavorable functional outcomes. Conclusion the eSAH score demonstrates strong external validity, reproducibility and superior predictive performance compared with conventional grading systems in a large multicenter cohort. These findings support the clinical utility of quantitative hemorrhage burden integration for early risk stratification in patients with aSAH.
From CHESS to CHECKMATE: A Practical Score for Predicting Shunt Dependency Following Subarachnoid Hemorrhage
Salman, Saif, Haidenberger, Flora, Ahmad, Mahlika, Albaramony, Nadia, Patel, Vishal , Peel, Jeffrey, Ombada, Mutaz , Gutierrez-Aguirre, Salvador, Toledo, Otávio de, Aguilar-Salinas, Pedro, Tawk, Rabih, Byrne, Richard, Hanel, Ricardo, Rabinstein, Alejandro, Salman, Saif , Jahromi, Behnam Rezai , Albaramony, N., Patel, Vishal N., Peel, Jeffrey B., Gutierrez‐Aguirre, Salvador F. , Toledo, Otavio F. De , Tawk, Rabih G. , Rabinstein, Alejandro A. , Freeman, William D.

Mayo Clinic

No container title available | July 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.07.18.26358389 Get It

Abstract Objective Shunt-dependent hydrocephalus is a common and costly complication of aneurysmal subarachnoid hemorrhage (aSAH), affecting up to 28% of survivors. Existing prediction tools, including the Chronic Hydrocephalus Ensuing from SAH Score (CHESS), have limited discriminative accuracy. We developed the CHECKMATE score, a clinically practical tool to improve prediction of ventriculoperitoneal shunt dependency after aSAH. Methods In this multicenter retrospective cohort of 486 patients with aSAH from Mayo Clinic (January 1, 2006-December 31, 2021), we used multivariable logistic regression and machine learning to identify independent predictors of ventriculoperitoneal shunt placement. The CHECKMATE score was derived from 5 weighted variables: symptomatic hydrocephalus (10 points), intraventricular hemorrhage (5 points), SAH volume greater than 10 mL (3 points), neutrophil-to-lymphocyte ratio greater than 12 (2 points), and 10-year incremental age thresholds starting at older than 60 years (1 point each). Results Of 486 patients (mean age, 56.3 years; 64.6% female), 137 (28.2%) required ventriculoperitoneal shunt placement. The CHECKMATE score achieved an area under the curve of 0.808 (compared to 0.737 for CHESS), with a sensitivity of 0.85, specificity of 0.67, and negative predictive value of 0.92 at the optimal cutoff of 14 points. Conclusions The CHECKMATE score outperforms CHESS for predicting ventriculoperitoneal shunt dependency after aSAH and is easily used at the bedside. Its high negative predictive value helps identify low-risk patients who may benefit from earlier external ventricular drain weaning and shorter hospital stays.
Fever of Unknown Origin Solved With Novel Diagnostic Tool
Pomerantz, Lauren , Saleh, Omar M. Abu, Griffin, Nick, Pomerantz, Lauren D , Saleh, Omar Abu , Griffin, Natalie E.

Mayo Clinic

Annals of Internal Medicine: Clinical Cases | July 21, 2026 | Volume: 5 | Issue: 7 | Pages: No page available

10.7326/aimcc.2026.0253 Get It

Comorbid Abetalipoproteinemia and Neurofibromatosis Type 1: Potential Clinical Implications of an Ultrarare Co-occurrence
Womack, Yaqqira H. M., Asif, Misha , Shamoun, Fadi E., Baudhuin, Linnea M. , Osundiji, Mayowa A. , Asif, Misha B, Osundiji, Mayowa Azeez , Womack, Yaqqira, Asif, Misha , Shamoun, Fadi

Mayo Clinic

Annals of Internal Medicine: Clinical Cases | July 21, 2026 | Volume: 5 | Issue: 7 | Pages: No page available

10.7326/aimcc.2026.0224 | PMID 42614189 Get It

Tobacco Use and Cessation Patterns Among Cancer Survivors: Results From Nine ECOG-ACRIN Cancer Research Group Trials
Rosen, Rachel , Lee, Ju‐Whei , Gareen, Ilana F. , Herman, B. , Fenech, Alyssa, Kircher, Sheetal , Carlos, Ruth C. , Kumar, Shaji , Mayer, Ingrid A. , Saba, Nabil F. , Fenske, Timothy S. , Neal, Joel W. , Hodi, F. Stephen , Kyriakopoulos, Christos E. , Tempany, Clare M. , Shanafelt, Tait D. , Mayer, IA , Rosen, Rachel L , Herman, Benjamin A , Kumar, Shaji K , Atkins, Michael B. , Hodi, Frank Stephen , Kyriakopoulos, Christos E , Tempany, Clare , Shanafelt, Tait D , Wagner, Lynne , Ostroff, Jamie S , Park, Elyse R , Saba, Nabil F , Fenech, Alyssa L. , Wagner, Lynne I.

Mayo Clinic

JCO Oncology Practice | July 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1200/op-25-01346 | PMID 42480004 Get It

PURPOSE Systematic integration of tobacco cessation treatment within cancer centers is needed to improve smoking cessation outcomes among cancer patients and survivors. The current study characterizes baseline rates of tobacco use, use of cessation support, and changes in tobacco use over time among 756 participants diagnosed with cancer and enrolled in 9 ECOG-ACRIN Cancer Research Group trials. MATERIALS AND METHODS Participants completed surveys at trial enrollment and at 3- and 6-month follow-ups. Descriptive statistics were used to characterize patient characteristics and selected items from the Cancer Patient Tobacco Use Questionnaire (C-TUQ). Generalized estimating equations were used to examine the time point effect on tobacco product use. RESULTS At baseline, 11% of participants (n = 740) currently smoked cigarettes. Among participants with data available at all time points (n = 443), prevalence of current smoking was stable over time, with 7.2% of participants (n = 32) reporting current smoking at baseline, 7.0% (n = 31) at the 3-month follow-up assessment, and 6.8% (n = 30) at the 6-month follow-up assessment. Most participants (n = 77/104) who smoked cigarettes within the year prior to their cancer diagnosis continued smoking after their diagnosis, and during (n = 44/72) and following completion (n = 30/46) of their treatment. Sixty-two percent of participants (n = 81) who were currently smoking at baseline reported using smoking cessation medication and 32.1% reported use of nonpharmacologic smoking cessation support since their cancer diagnosis. In longitudinal analyses, the odds of using cigarettes since their cancer diagnosis, 3-month follow-up, and 6-month follow-up was higher than the odds of using cigarettes for the past 30 days at baseline (odds ratio [OR] = 1.97, OR = 1.62, and OR = 1.50, respectively; all p s < .01). CONCLUSION Smoking persists over time among patients with cancer enrolled in therapeutic cancer trials. Findings highlight the importance of increasing access to integrated and longitudinal smoking cessation support.